Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Total Current Liabilities: 2022-2023

  • Lexeo Therapeutics' Total Current Liabilities was N/A to $23.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $23.0 million, marking a year-over-year change of. This contributed to the annual value of $14.3 million for FY2022, which is N/A change from last year.
  • Per Lexeo Therapeutics' latest filing, its Total Current Liabilities stood at $23.0 million for Q3 2023, which was up 60.53% from $14.3 million recorded in Q4 2022.
  • Lexeo Therapeutics' 5-year Total Current Liabilities high stood at $23.0 million for Q3 2023, and its period low was $14.3 million during Q4 2022.
  • For the 2-year period, Lexeo Therapeutics' Total Current Liabilities averaged around $18.7 million, with its median value being $18.7 million (2022).